Stanford study links GLP-1 weight-loss therapies to improved employment and relationship outcomes

Research by Stanford economist Rebecca Diamond indicates that patients undergoing GLP-1 therapy for obesity and diabetes show increased rates of employment and relationship formation. The study suggests these outcomes are driven by reduced social stigma associated with weight, though the causal mechanisms remain subject to broader socioeconomic variables.